[Clinical study on tuberactinomycin, a new antibiotic].
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014756:Viomycin
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D014756:Viomycin